Clinical Trial

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

Study acronym: IL-2
Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated October 20, 2025 (before its estimated July 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 1, open-label, multi-center, competitive enrollment, and dose-escalation study of HCW9302 in subjects with Alopecia Areata (AA)
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-24; most recent amendment 2025-10-16.
Status change: Not Yet Recruiting → Recruiting 2025-08-28
Trial Details
NCT Number NCT07049328
Lead Sponsor HCW Biologics
Conditions Alopecia Areata(AA)
Enrollment 30 participants
Start Date 2025-08-16
Primary Completion 2026-07-16 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-10-20